Diarrhea – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions.
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.
The Diarrhea drugs in development market research report provide comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diarrhea and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Diarrhea | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 56 molecules, with 47 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Diarrhea therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Diarrhea pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Diarrhea treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AbbVie IncAngelini Pharma SpA
Avivia BV
Boston Pharmaceuticals Inc
Brillian Pharma Inc.
Chongqing Zhifei Biological Products Co Ltd
Cosmo Pharmaceuticals NV
Glycosyn LLC
Hilleman Laboratories Pvt Ltd
Immuron Ltd
Intrinsic Medicine Inc
Jaguar Health Inc
Johns Hopkins University
Lumen Bioscience Inc
MyBiotics Pharma Ltd
Napo Pharmaceuticals Inc
Napo Therapeutics SpA
NGM Biopharmaceuticals Inc
Nuvara Therapeutics LLC
OnQuality Pharmaceuticals LLC
OnQuality Pharmaceuticals Ltd
Orphomed Inc
PATH
Prokarium Ltd
Prosetta Biosciences Inc
Protagonist Therapeutics Inc
RaQualia Pharma Inc
RedHill Biopharma Ltd
RxBio Inc
Scandinavian Biopharma Holding AB
Shanghai Pharmaceuticals Holding Co Ltd
Syntiron LLC
TenNor Therapeutics Ltd
The Institute of Medical Science The University of Tokyo
Theriva Biologics Inc
University of Bergen
University of Minnesota
University of Tennessee Research Foundation
US Army Medical Research & Materiel Command
Vanda Pharmaceuticals Inc
Vanderbilt University
Vanessa Biotech
Vir Biotechnology Inc
Viscera Labs Inc
Werteks Pharmaceutical Co
Wuhan Healthgen Biotechnology Corp
Wuhan Institute of Biological Products Co Ltd
Yisheng Biopharma Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Diarrhea reports